Crystal Structures of HIV-1 Reverse Transcriptase with Picomolar Inhibitors Reveal Key Interactions for Drug Design — Kathleen M. Frey (2012) | RDL Network
Crystal Structures of HIV-1 Reverse Transcriptase with Picomolar Inhibitors Reveal Key Interactions for Drug Design
Journal of the American Chemical Society 134(48): 19501-19503
Article 2012 English
Authors
KF
Kathleen M. Frey
MB
Mariela Bollini
AM
Andrea C. Mislak
Abstract
1 min read
X-ray crystal structures at 2.9 Å resolution are reported for two complexes of catechol diethers with HIV-1 reverse transcriptase. The results help elucidate the structural origins of the extreme antiviral activity of the compounds. The possibility of halogen bonding between the inhibitors and Pro95 is addressed. Structural analysis reveals key interactions with conserved residues P95 and W229 of importance for design of inhibitors with high potency and favorable resistance profiles.
William T. Gray, Kathleen M. Frey, Sarah B. Laskey, Andrea C. Mislak, Krasimir A. Spasov, Won-Gil Lee, Mariela Bollini, Robert F. Siliciano, William L. Jorgensen, Karen S. Anderson
Klarissa Hollander, Albert H. Chan, Kathleen M. Frey, Olivia Hunker, Joseph A. Ippolito, Krasimir A. Spasov, Yang-Hui Jimmy Yeh, William L. Jorgensen, Ya‐Chi Ho, Karen S. Anderson
Discussion(0)
No comments yet. Be the first to comment.